Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(33.3%)
N/A
1(33.3%)
Early Phase 1
1(33.3%)
3Total
Phase 1(1)
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01781936Phase 1Completed

Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis

Role: lead

NCT00952614Not ApplicableCompleted

A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein Occlusion

Role: lead

NCT00636493Early Phase 1Completed

Fluocinolone Acetonide Implant for Retinal Vein Occlusion (RVO)

Role: lead

All 3 trials loaded